论文部分内容阅读
目的:观察炎琥宁联合头孢曲松钠在治疗小儿支气管炎的治疗效果。方法:按照对照组与观察组各43例,将86例支气管炎患儿平均分配。对两组患儿分别采取相对症治疗方法,在对照组采取头孢曲松钠的治疗;在治疗组中则在采用头孢曲松钠的基础上加以炎琥宁的注射治疗。在2组进行为期7d的治疗过程中观察治疗的结果。结果:经计算统计得,对照组总有效率为76.6%,在观察组中,存在着93.6%的总有效率,差异很大,存在统计学意义(P<0.05).结论:炎琥宁联合头孢曲松钠在治疗小儿支气管炎方面安全可靠且治疗效果显著。
Objective: To observe the effect of combination of mesylate and ceftriaxone in the treatment of pediatric bronchitis. Methods: In accordance with the control group and the observation group of 43 cases, the average of 86 cases of bronchitis children allocated. The two groups of children were treated with relative symptomatic treatment in the control group to take ceftriaxone sodium treatment; in the treatment group is based on the use of ceftriaxone sodium injection treatment. The results of the treatment were observed during the 7 days of treatment in both groups. Results: The calculated total effective rate was 76.6% in the control group, 93.6% of the total effective rate in the observation group, the difference was statistically significant (P <0.05) .Conclusion: Ceftriaxone sodium in the treatment of pediatric bronchitis safe and reliable and the treatment effect is remarkable.